Square Pharmaceuticals Limited announced earnings results for the third quarter ended March 31, 2019. For the third quarter, the company announced sales was BDT 12,563.436 million compared to BDT 11,386.481 million a year ago. Operating income was BDT 3,493.565 million compared to BDT 3,329.697 million a year ago. Net income was BDT 3,118.611 million compared to BDT 2,975.818 million a year ago. Basic earnings per share was BDT 3.95 compared to BDT 3.77 a year ago. For the nine months, sales was BDT 37,306.477 million compared to BDT 34,247.876 million a year ago. Operating income was BDT 10,548.938 million compared to BDT 9,820.014 million a year ago. Net income was BDT 9,413.843 million compared to BDT 8,840.211 million a year ago. Basic earnings per share was BDT 11.93 compared to BDT 11.2 a year ago.